Gene · 81607
Papers1,879
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,879
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Squamous cell carcinoma of the bladder: Current evidence, therapeutic challenges, and research perspectives from the French AVENTUR group. | Crit Rev Oncol Hematol | 2026 | 42520864 | PubTator, text mining | PubMed |
| Enfortumab Vedotin in Advanced or Metastatic Urothelial Carcinoma: A Systematic Review of Efficacy, Safety, and Clinical Perspectives. | Cancers (Basel) | 2026 | 42512387 | PubTator, text mining | PubMed |
| Immunohistochemical, Immunofluorescent, and Molecular Investigation of Canine Distemper Virus, Nectin 4, and CD150 Receptors in Naturally Infected Dogs with Canine Distemper Virus. | Animals (Basel) | 2026 | 42511110 | PubTator, text mining | PubMed |
| Antibody Drug Conjugates in Urothelial Carcinoma: Current Evidence and Practice Considerations. | JCO Oncol Pract | 2026 | 42507977 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of Novel Therapeutic Targets in Squamous Cell Carcinoma of the Bladder. | Oncol Res | 2026 | 42500580 | PubTator, text mining | PubMed |
| An Overview of Emerging Trends in Targeted Therapy of Triple-Negative Breast Cancer. | Int J Breast Cancer | 2026 | 42488779 | PubTator, text mining | PubMed |
| The expression landscape and heterogeneity of nectin-4, HER2, and Trop-2 in urothelial carcinoma: clinicopathological correlations and implications for ADC-guided precision therapy. | Front Oncol | 2026 | 42488113 | PubTator, text mining | PubMed |
| Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects. | Cancer Lett | 2026 | 42480966 | PubTator, text mining | PubMed |
| Nectin4 restricts pseudorabies virus infection by blocking gD-Nectin1 interaction. | J Virol | 2026 | 42474184 | PubTator, text mining | PubMed |
| Nectin-4 Expression in Muscle-Invasive Bladder Cancer Is Associated with Growth-Related and Inflammatory Signaling Pathways. | Int J Mol Sci | 2026 | 42449979 | PubTator, text mining | PubMed |
| Incidence and Spectrum of Adverse Events With Enfortumab Vedotin Therapy in Advanced or Metastatic Urothelial Carcinoma: Evidence From a Systematic Review and Meta-Analysis. | Arch Esp Urol | 2026 | 42438880 | PubTator, text mining | PubMed |
| Site-specific differences in Nectin-4 expression and associated immune contexture in advanced urothelial carcinoma: implications for Nectin-4-targeted ADCs. | Ther Adv Med Oncol | 2026 | 42422333 | PubTator, text mining | PubMed |
| Nectin-4 as predictive biomarker of immune-related adverse event subtypes in adjuvant anti-programmed-death-1 treatment of melanoma. | Melanoma Res | 2026 | 42421561 | PubTator, text mining | PubMed |
| [Update: Evolution in the management of metastatic urothelial carcinomas]. | Bull Cancer | 2026 | 42409721 | PubTator, text mining | PubMed |
| Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease: Elucidating Heart-Brain Connections. | JACC Basic Transl Sci | 2026 | 42385440 | PubTator, text mining | PubMed |
| A novel monoclonal antibody targeting the hemagglutinin-neuraminidase of peste des petits ruminants virus maintains neutralizing activity by blocking viral adsorption and receptor interaction. | J Virol | 2026 | 42383740 | PubTator, text mining | PubMed |
| Acute Cardiac Tamponade Following Enfortumab Vedotin Initiation in Metastatic Urothelial Carcinoma: Successful Rescue by Pericardial Fenestration. | IJU Case Rep | 2026 | 42382317 | PubTator, text mining | PubMed |
| Plasma nectin-4 levels are associated with changes in executive function in patients with methamphetamine use disorder undergoing treatment. | Behav Brain Res | 2026 | 42379379 | PubTator, text mining | PubMed |
| Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors. | Cancer Res Commun | 2026 | 42378456 | PubTator, text mining | PubMed |
| Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine. | Expert Rev Anticancer Ther | 2026 | 42376796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81607/papers?page=3